Literature DB >> 12561238

Synthesis of some new bis-thiazoles as possible anticancer agents.

H T Y Fahmy1, A A Bekhit.   

Abstract

Several new 5-(2,3-dihydrothiazol-2-yledinyl)rhodanines 3a-c and 5-(4-oxothiazolidinon-2-ylidenyl)rhodanine 4 were synthesized through the reaction of 5-thiocarbamoyl rhodanines 2 with phenacyl bromides or chloroacetic acid, respectively. The synthesis of the arylidene derivatives 5a-c were also described. The 5-(4-amino-5-cyano-2,3-dihydrothiazol-2-yledinyl)rhodanines 10a, b were obtained through reaction of rhodanines 1a, b with thiazolium salt 9. All the prepared compounds were screened for their anticancer activity using the NCI in vitro anticancer screening program. Three compounds showed promising anticancer activity against particular human cell lines used in the assay.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12561238

Source DB:  PubMed          Journal:  Pharmazie        ISSN: 0031-7144            Impact factor:   1.267


  4 in total

1.  (E)-3-Methyl-5-(4-methyl-phen-oxy)-1-phenyl-1H-pyrazole-4-carbaldehyde O-[(2-chloro-1,3-thia-zol-5-yl)meth-yl]oxime.

Authors:  Hong Dai; Yu-Ting Zhang; Yu-Jun Shi; Wen-Wen Zhang; Yong-Jun Shen
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-02-26

2.  5-(3-Chloro-phen-ylsulfan-yl)-1-methyl-3-trifluoro-methyl-1H-pyrazole-4-carbaldehyde O-[(2-chloro-1,3-thia-zol-5-yl)meth-yl]oxime.

Authors:  Hong Dai; Shuang Li; Kun-Peng Luo; Jian-Xin Fang; Yu-Jun Shi
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-12-17

3.  Synthesis and anticancer activity of novel quinazolinone-based rhodanines.

Authors:  Sherihan El-Sayed; Kamel Metwally; Abdalla A El-Shanawani; Lobna M Abdel-Aziz; Harris Pratsinis; Dimitris Kletsas
Journal:  Chem Cent J       Date:  2017-10-13       Impact factor: 4.215

4.  Exploring 2-Tetradecanoylimino-3-aryl-4-methyl-1,3-thiazolines Derivatives as Alkaline Phosphatase Inhibitors: Biochemical Evaluation and Computational Analysis.

Authors:  Aftab Ahmed; Sajid-Ur Rehman; Syeda Abida Ejaz; Aamer Saeed; Rabail Ujan; Pervaiz Ali Channar; Khalida Mahar; Reshma Sahito; Sarah M Albogami; Qamar Abbas; Mohammed Alorabi; Michel De Waard; Gaber El-Saber Batiha
Journal:  Molecules       Date:  2022-10-10       Impact factor: 4.927

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.